Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03855241 · ClinicalTrials.gov registry record · NA
Safely Disposing of Surplus Prescription Opioids
A NA study of Opioid Use, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 499
- Enrollment target
- 1
- Study location
NCT03855241: Completed NA study of Opioid Use, sponsored by Johns Hopkins University.
NCT03855241 is a NA study of Opioid Use that has completed, run by Johns Hopkins University. The registered enrollment target is 499 participants, below the 148,255-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03855241, a NA study of Opioid Use, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 499 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates two interventions intended to increase the safe disposal of leftover prescription opioids, compared to no intervention. Participants will receive an informational sheet describing how to safely dispose of leftover prescription opioids, an informational sheet with a drug disposal kit, or no intervention. Participants will be randomized by day for pragmatic reasons.
Primary Outcome
Participants who report "yes" to disposing of leftover prescription opioid medication using a disposal intervention that aligns with recommendations from the Food and Drug Administration (i.e., using a take-back program, drug disposal kit, or flushing in the toilet)
Conditions Studied
Interventions
- BEHAVIORAL Informational Sheet
- BEHAVIORAL DisposeRx Drug Disposal kit
Study Locations (1)
Maryland
- Johns Hopkins Hospital/Johns Hopkins Outpatient Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 499 participants |
| Start Date | 2019-06-05 |
| Est. Completion | 2019-08-14 |
| Phase | NA |
What the finished NCT03855241 record still lists
NCT03855241 is an interventional study that assigns participants to a tested intervention. The registered 499 participants enrollment target is mid-sized for trials with a published cap, below the 148,255-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Opioid Use appearing as the primary indexed condition, and to 2 interventions - of which Informational Sheet is the first listed.
NCT03855241 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT03855241 about?
NCT03855241 is a clinical study titled "Safely Disposing of Surplus Prescription Opioids". This study evaluates two interventions intended to increase the safe disposal of leftover prescription opioids, compared to no intervention. Participants will receive an informational sheet describing how to safely dispose of leftover prescription opioids, an informational sheet with a drug disposal...
What is the current status of trial NCT03855241?
This trial is currently completed. It is a NA study. The enrollment target is 499 participants. The study started on 2019-06-05. Estimated completion is 2019-08-14.
What conditions does trial NCT03855241 study?
This clinical trial studies the following conditions: Opioid Use.
What interventions are being tested in trial NCT03855241?
The interventions under investigation include: Informational Sheet (BEHAVIORAL), DisposeRx Drug Disposal kit (BEHAVIORAL).
Who is sponsoring clinical trial NCT03855241?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03855241 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03855241's enrollment target sits among peer trials
499 17th of 105 higher than 89 of 105 other Opioid Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
QL vs LAI for Palatoplasty
RECRUITING · NA
-
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
RECRUITING · NA
-
Hip Arthroscopy Postoperative Opioid Demands
RECRUITING · NA
-
Neuroimaging of Opioid Phase (OPAL)
RECRUITING · NA
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04137900 · 499 participants · Phase 1
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
- NCT06733480 · 499 participants · NA
Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI